rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutations of the BRAF gene in human cancer.
|
12068308 |
2002 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutations of the BRAF gene in human cancer.
|
12068308 |
2002 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD).
|
18186519 |
2008 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Mutations of the BRAF gene in human cancer.
|
12068308 |
2002 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.
|
20350999 |
2010 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
The road to resistance: EGFR mutation and cetuximab.
|
22310681 |
2012 |
rs121913370
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913351
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
|
21129611 |
2010 |